The risks of non‐fatal MI, stroke, and ischemia‐driven repeat revascularization were numerically higher in the moderate‐to‐severe CKD group but did not reach statistical significance (all p > 0.05) (Table 2 ). 3.3 Secondary Outcomes Pharmacological treatment is detailed in Supporting Information S1: Table 1 .
← all excerpts
Impact of Chronic Kidney Disease Severity on Clinical Outcomes After Drug-Eluting Stent Implantation: A Propensity Score-Matched Analysis.
1
0.0500
0.0500